Aminoacidi con gruppi protettivi

Fmoc-Tyr-OH is a peptide that can be used as an agent for the treatment of epidermal growth factor receptor (EGFR) related diseases. It has been shown to be effective in inhibiting the replication of RNA and DNA, which may contribute to the inhibition of tumor growth. Fmoc-Tyr-OH is synthesized through solid phase synthesis where it is reacted with trifluoroacetic acid and particle. This reaction is enhanced by adding an iodination reaction and phosphatase. The polymerase chain reaction then occurs in order to produce more Fmoc-Tyr-OH peptides. Fmoc-Tyr-OH also has a high affinity for acidic ph, making it suitable for use in acidic environments such as tumors.

Fmoc-4,4-difluoro-L-proline is an antibacterial that binds to the bacterial cell wall by competitive inhibition. Fmoc-4,4-difluoro-L-proline has been shown to be effective in treating inflammatory bowel disease and other inflammatory diseases, such as traumatic brain injury and Alzheimer's disease. Fmoc-4,4-difluoro-L-proline also has inhibitory effects on a number of enzymes, including dehydrogenase and caspases. This drug may also have therapeutic potential for degenerative diseases and autoimmune diseases such as infectious diseases. 6 Fluoro 3 indoxyl beta D galactopyranoside Rifapentine is an anti tuberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding

N-alpha-Fmoc-Nepsilon-dansyl-L-lysine is a fluorescent molecule that is synthesized by attaching an allyl group to the amino acid lysine. This fluorescence can be used as a probe for specific interactions with proteins. N-alpha-Fmoc-Nepsilon-dansyl-L-lysine has been shown to interact with copolymers of poly(ethylene glycol) and poly(allylamine). The interaction results in a supramolecular, or self assembling, structure. The molecule's fluorescence can be activated by irradiation and this makes it useful for studying protein target binding.

Fmoc-D-Arg(Pbf)-OH is a synthetic peptide that can inhibit the growth of cancer cells. It has been shown to inhibit protease activity in mitochondria and inhibit mitochondrial membrane potential. The uptake of Fmoc-D-Arg(Pbf)-OH by neutrophils is dependent on the presence of superparamagnetic iron nanoparticles, which are taken up by phagocytic cells and used for oxidative burst. Fmoc-D-Arg(Pbf)-OH has a high affinity for mammalian cells but not for bacterial or fungal cells.

Fmoc-OSu is a matrix that can be used as an absorption enhancer in biological and biochemical studies. The ester hydrochloride form of Fmoc-OSu is soluble in water and methanol, but not in organic solvents such as chloroform or ether. Fmoc-OSu is also a fluorescent derivative that can be used to label glycan structures in primary cells. The reaction solution with anhydrous sodium carbonate and glycan produces a cyclic peptide. This reaction is carried out at room temperature with analytical methods using a spectrophotometer or high performance liquid chromatography (HPLC).

Fmoc-L-norleucine is a non-natural amino acid that can be used to study the interactions of proteins with cellular receptors. It is synthesized from methylandrostenediol and caproic acid, which are then reacted with sodium salt. The resultant product contains a tertiary amine group that interacts with the surface receptor. Fmoc-L-norleucine has shown affinity for endogenous ligands such as nucleobases and phospholipids on cell membranes. In addition, it has been shown to interact with other proteins through its side chain, including erythrocyte band 3 protein. Fmoc-L-norleucine also has a high affinity for binding to divalent metal ions such as calcium and magnesium in aqueous solution, giving it potential applications in the field of analytical chemistry.

Fmoc-Asp(OtBu)-OH is a fluorescent probe that binds to the integrin receptor. This protein is a cell-surface receptor that binds to collagen, fibronectin and other extracellular matrix proteins. Fmoc-Asp(OtBu)-OH has been shown to inhibit the binding of human cells to collagen in a homogenous assay. The chemical ligation of this amino acid with an amine results in an isopeptide bond, which can be cleaved by trifluoroacetic acid. Fmoc-Asp(OtBu)-OH can be used for the detection of integrin receptors in mammalian cells and sectioned tissues.

N-Fmoc-4-methanesulfonylamino-L-phenylalanine is a versatile building block that is used in the synthesis of complex compounds. It can be used as a reagent or speciality chemical, and has been shown to be an effective building block for the synthesis of high quality compounds. N-Fmoc-4-methanesulfonylamino-L-phenylalanine is soluble in water and meets USP requirements for purity. This compound can be used as an intermediate, scaffold, or reaction component.

Fmoc-5-hydroxy-L-Nva-OH is a useful building block and reagent that belongs to the group of speciality chemicals. It is a versatile compound that can be used as a reaction component, useful intermediate, or useful scaffold. Fmoc-5-hydroxy-L-Nva-OH is an important building block for organic synthesis. It has been shown to be a good substitute for expensive natural products in the synthesis of pharmaceuticals and other organic compounds.

Please enquire for more information about Fmoc-(R)-3-amino-3-(3-trifluoromethyl-phenyl)-propionic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fmoc-Trp(5-OH)-OH is a molecule that has been shown to have anticancer activity. It inhibits the proliferation of cancer cells and inhibits the production of fatty acids. It also has antiinflammatory properties and inhibits the growth of bacteria by inhibiting chloride channels. Fmoc-Trp(5-OH)-OH has been shown to inhibit the binding of 4-methylumbelliferone (4MU) to human erythrocytes, which is an indicator of its capability as a coumarin derivative. Fmoc-Trp(5-OH)-OH has also been found to be effective against tuberculosis through hydrogen bond interactions with the enzyme mycobacterium tuberculosis DNA polymerase.